Correlation Between Fate Therapeutics and Gossamer Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Gossamer Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Gossamer Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Gossamer Bio, you can compare the effects of market volatilities on Fate Therapeutics and Gossamer Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Gossamer Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Gossamer Bio.

Diversification Opportunities for Fate Therapeutics and Gossamer Bio

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Fate and Gossamer is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Gossamer Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gossamer Bio and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Gossamer Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gossamer Bio has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Gossamer Bio go up and down completely randomly.

Pair Corralation between Fate Therapeutics and Gossamer Bio

Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Gossamer Bio. But the stock apears to be less risky and, when comparing its historical volatility, Fate Therapeutics is 1.08 times less risky than Gossamer Bio. The stock trades about -0.02 of its potential returns per unit of risk. The Gossamer Bio is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  240.00  in Gossamer Bio on October 15, 2024 and sell it today you would lose (143.00) from holding Gossamer Bio or give up 59.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fate Therapeutics  vs.  Gossamer Bio

 Performance 
       Timeline  
Fate Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Gossamer Bio 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Gossamer Bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Gossamer Bio may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Fate Therapeutics and Gossamer Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fate Therapeutics and Gossamer Bio

The main advantage of trading using opposite Fate Therapeutics and Gossamer Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Gossamer Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will offset losses from the drop in Gossamer Bio's long position.
The idea behind Fate Therapeutics and Gossamer Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio